These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Postural control, gait, and dopamine functions in parkinsonian movement disorders. Bohnen NI; Cham R Clin Geriatr Med; 2006 Nov; 22(4):797-812, vi. PubMed ID: 17000336 [TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism. Mostile G; Nicoletti A; Cicero CE; Cavallaro T; Bruno E; Dibilio V; Luca A; Sciacca G; Raciti L; Contrafatto D; Chiaramonte I; Zappia M Neurol Sci; 2016 Apr; 37(4):591-5. PubMed ID: 26820655 [TBL] [Abstract][Full Text] [Related]
27. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease? Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107 [TBL] [Abstract][Full Text] [Related]
28. MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. Quattrone A; Morelli M; Williams DR; Vescio B; Arabia G; Nigro S; Nicoletti G; Salsone M; Novellino F; Nisticò R; Pucci F; Chiriaco C; Pugliese P; Bosco D; Caracciolo M Neurology; 2016 Sep; 87(12):1266-73. PubMed ID: 27558375 [TBL] [Abstract][Full Text] [Related]
34. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659 [TBL] [Abstract][Full Text] [Related]
35. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy. Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300 [TBL] [Abstract][Full Text] [Related]
36. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population. Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564 [TBL] [Abstract][Full Text] [Related]
37. Clinical and MRI features of gait and balance disorders in neurodegenerative diseases. Sarasso E; Filippi M; Agosta F J Neurol; 2023 Mar; 270(3):1798-1807. PubMed ID: 36577818 [TBL] [Abstract][Full Text] [Related]
38. The Differential Diagnosis and Treatment of Atypical Parkinsonism. Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156 [TBL] [Abstract][Full Text] [Related]
39. Caribbean parkinsonism and other atypical parkinsonian disorders. Tolosa E; Calandrella D; Gallardo M Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S19-26. PubMed ID: 15109583 [TBL] [Abstract][Full Text] [Related]
40. Progressive spasticity, supranuclear gaze palsy and postural instability, without parkinsonism: what's in a phenotype? Ricciardi L; Edwards MJ; Fasano A; Bhatia KP; Stamelou M J Neurol Sci; 2018 Jul; 390():84-86. PubMed ID: 29801913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]